inclusion criteria: * male and non-pregnant female patients 18 years of age or older * positive rt-pcr for sars-cov-2. * fever (oral t≥39 c within 24 hours of enrollment), tachypnea (resting respiratory rate ≥ 28/min) and/or oxygen saturation (sao2) ≤ 93% on room air. * ability to read, understand and sign irb approved informed consent * patients on hcq or hcq/az already are eligible for randomization.

inclusion criteria: * male and non-pregnant female patients 18 years of age or older * positive rt-pcr for sars-cov-2. * fever (oral t≥39 c within 24 hours of enrollment), tachypnea (resting respiratory rate ≥ 28/min) and/or oxygen saturation (sao2) ≤ 93% on room air. * ability to read, understand and sign irb approved informed consent * patients on hcq or hcq/az already are eligible for randomization.

inclusion criteria: - male and non-pregnant female patients 18 years of age or older - positive rt-pcr for sars-cov-2. - fever (oral t≥39 c within 24 hours of enrollment), tachypnea (resting respiratory rate ≥ 28/min) and/or oxygen saturation (sao2) ≤ 93% on room air. - ability to read, understand and sign irb approved informed consent - patients on hcq or hcq/az already are eligible for randomization.

inclusion criteria: - male and non-pregnant female patients 18 years of age or older - positive rt-pcr for sars-cov-2. - fever (oral t≥39 c within 24 hours of enrollment), tachypnea (resting respiratory rate ≥ 28/min) and/or oxygen saturation (sao2) ≤ 93% on room air. - ability to read, understand and sign irb approved informed consent - patients on hcq or hcq/az already are eligible for randomization.